Market Place
Sourcing Support
Akari Therapeutics, WuXi XDC Team Up on ADC Payload
06 Apr 2026 //
GLOBENEWSWIRE
Akari Pharma To Present Abstract At Aacr Annual Meeting 2026
18 Mar 2026 //
GLOBENEWSWIRE
Akari Therapeutics Announces ADS Ratio Change
17 Mar 2026 //
GLOBENEWSWIRE
Akari Therapeutics To Present At 2026 Biocom Global Conference
18 Feb 2026 //
GLOBENEWSWIRE
Akari Pharma Joins Virtual `What This Means` ADC Interview
11 Feb 2026 //
GLOBENEWSWIRE
Akari Pharma Files Vital Patent, Reveals AKTX-102 For CEACAM5
26 Jan 2026 //
GLOBENEWSWIRE
Akari Therapeutics: 2025 Progress, 2026 Outlook
09 Jan 2026 //
GLOBENEWSWIRE
Akari Therapeutics To Present At The 2026 Biotech Showcase
08 Jan 2026 //
GLOBENEWSWIRE
Akari Pharma Starts GMP Production For AKTX-101 ADC In Phase 1
23 Dec 2025 //
GLOBENEWSWIRE
Akari Pharma Unveils Virtual Investor Insight Segment
18 Dec 2025 //
GLOBENEWSWIRE
Akari Highlights AKTX-101`s Promise in K-Ras Pancreatic Cancer
09 Dec 2025 //
GLOBENEWSWIRE
Akari Pharma Updates On ADC Payload Innovation In New CEO Corner
04 Dec 2025 //
GLOBENEWSWIRE
Akari Pharma Unveils New CEO Corner Segment
25 Nov 2025 //
GLOBENEWSWIRE
Akari Therapeutics Names Farag as Interim CFO
18 Nov 2025 //
GLOBENEWSWIRE
Akari Therapeutics Presents Splicing-Targeted ADC Payload Data
10 Nov 2025 //
GLOBENEWSWIRE
Akari Releases Abstract on Splicing-Targeted ADC Payload
04 Nov 2025 //
GLOBENEWSWIRE
Akari Pharma Forms Scientific Advisory Board, Appoints Renowned
30 Oct 2025 //
GLOBENEWSWIRE
Akari Therapeutics Announces Launch Of CEO Corner Platform
22 Oct 2025 //
GLOBENEWSWIRE
Akari Pharma Reveals $2.5M Direct Offering
15 Oct 2025 //
GLOBENEWSWIRE
Akari Files Two Patents for Immuno-Oncology ADC Platform PH1
09 Oct 2025 //
GLOBENEWSWIRE
Akari Pharma To Present Abstract At 40Th (SITC) Conference
03 Oct 2025 //
GLOBENEWSWIRE
Akari Therapeutics Shows Novel ADC Spliceosome Modulating Payload
24 Sep 2025 //
GLOBENEWSWIRE
Akari Pharma Files New Patent for ADC Platform with Spliceosome
17 Sep 2025 //
GLOBENEWSWIRE
Akari Therapeutics to Present at HC Wainwright Global Conference
05 Sep 2025 //
GLOBENEWSWIRE
Akari Therapeutics Joins Virtual Investor Closing Bell Series
03 Sep 2025 //
GLOBENEWSWIRE
Akari Therapeutics to Present at Webull Financial Webinar
14 Aug 2025 //
GLOBENEWSWIRE
Akari Therapeutics Unveils Virtual Investor Segment
29 Jul 2025 //
GLOBENEWSWIRE
Akari Advances PH1 Antibody Drug for Oncogenic Cancers
23 Jul 2025 //
GLOBENEWSWIRE
Akari Highlights India Patent in Virtual Investor Segment
25 Jun 2025 //
GLOBENEWSWIRE
Akari Therapeutics strengthens global IP for ADC PH1 with Indian
18 Jun 2025 //
GLOBENEWSWIRE
Akari Therapeutics Releases "Meet the Team" Video with Mark F.
29 May 2025 //
GLOBENEWSWIRE
Akari To Present At Webull’s Virtual Biotech Investment Event
22 May 2025 //
GLOBENEWSWIRE
Akari Therapeutics Reports Q1 2025 Financial Results
15 May 2025 //
GLOBENEWSWIRE
Akari Therapeutics Releases Welcome Video from New CEO Abizer Gas
22 Apr 2025 //
GLOBENEWSWIRE
Akari Therapeutics Reports 2024 Financial Results and Update
16 Apr 2025 //
GLOBENEWSWIRE
Akari Therapeutics Names Abizer Gaslightwala President and CEO
20 Mar 2025 //
GLOBENEWSWIRE
Akari Announces $7.6M Private Placement Under Nasdaq Rules
03 Mar 2025 //
GLOBENEWSWIRE
Akari Therapeutics Joins Virtual Investor "Top 5 for `25" Event
19 Feb 2025 //
GLOBENEWSWIRE
Akari Therapeutics Joins Webull Corporate Connect Service Platform
03 Feb 2025 //
GLOBENEWSWIRE
Akari Completes Merger with Peak Bio Successfully
14 Nov 2024 //
GLOBENEWSWIRE
Akari Therapeutics Shareholder Approval for Peak Bio Merger
08 Nov 2024 //
GLOBENEWSWIRE
Akari Therapeutics Announces Effectiveness of Form S-4 and On Nov 7
15 Oct 2024 //
GLOBENEWSWIRE
Rob Bazemore Joins Akari Therapeutics Board of Directors
17 Sep 2024 //
GLOBENEWSWIRE
Akari Therapeutics Receives Positive FDA Feedback On PAS-Nomacopan
19 Aug 2024 //
GLOBENEWSWIRE
Akari Therapeutics Reports Q2 2024 Financial Results And Highlights
19 Aug 2024 //
GLOBENEWSWIRE
Akari Therapeutics Reports Q1 2024 Financials, Highlights
16 May 2024 //
GLOBENEWSWIRE
Akari, Peak Bio Plan For Post-Merger Pipeline Prioritization
01 May 2024 //
GLOBENEWSWIRE
Akari To Present PAS-Nomacopan ERG Data At ARVO 2024
15 Apr 2024 //
GLOBENEWSWIRE
Akari Therapeutics to Present at Biotech Showcase 2024
14 Dec 2023 //
GLOBENEWSWIRE
Akari Presents Poster on Progress in Development of PAS-Nomacopan
16 Nov 2023 //
GLOBENEWSWIRE
Akari to Present a Poster on Development of Long-Acting PAS-Nomacopan
06 Nov 2023 //
GLOBENEWSWIRE
Akari Receives +ve Opinion on ODD from the EMA for Nomacopan
06 Jul 2023 //
GLOBENEWSWIRE
Akari Announces a Case Study from the Phase 3 Part A Clinical Trial of Nomacopan
03 Apr 2023 //
GLOBENEWSWIRE
Poland and URPL and MHRA Approve Use of Nomacopan
29 Mar 2023 //
GLOBENEWSWIRE
Akari Announces Presentation of Study from PIII Part A Trial of Nomacopan
21 Feb 2023 //
GLOBENEWSWIRE
Akari Announces Progress Toward IND on PAS-Nomacopan for GA
15 Feb 2023 //
GLOBENEWSWIRE
Akari Announces Acceleration of the Phase 3 Clinical Trial of Nomacopan
13 Feb 2023 //
GLOBENEWSWIRE
Akari Therapeutics to Present at Biotech Showcase 2023
04 Jan 2023 //
GLOBENEWSWIRE
